New T2 drug from Sanofi-Aventis proving successful in trials
Sanofi-Aventis said that lixisenatide, an experimental Type 2 diabetes drug, has been very successful in a late stage trial at helping patients reduce their blood
Sanofi-Aventis said that lixisenatide, an experimental Type 2 diabetes drug, has been very successful in a late stage trial at helping patients reduce their blood
JDRF has extended a jointly-funded research programme with Johnson & Johnson (which has the diabetes-specific Lifescan and Animas brands in the UK) focused on developing therapies
Medtronic has launched the Enlite Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring (CGM), in the UK combining greater comfort with
In an aticle from Diabetes Newshound, “Once Type 1 diabetes begins to develop, there is no stopping it. While the process can take years, the
Yes, there is a a National Stop Snoring week, and it starts on 9th of May. What kind of snorer are you? You can check
The International Diabetes Federation (IDF) has launched the first ever Charter setting out the fundamental rights of more than 300 million people living with diabetes.
Diabetes UK Northern & Yorkshire is hosting a golf tournament to raise money for Diabetes UK. It is being held at Moor Allerton Golf Club,
This neat little bundle is the Mio, the newest infusion set to be added to the Medtronic range. An all-in-one set, the Mio has an
Mighty Muesli is small East Devon muesli manufacturer. It’s main product, Mighty Muesli, has a unique recipe based on a blend of 22 different ingredients
We can all, at times, suffer with dark circles under the eyes; redness; puffiness from sinus problems or allergies; tiredness from too much close-up computer